We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$22.4B
AUM Growth
+$2.53B
Cap. Flow
+$632M
Cap. Flow %
2.82%
Top 10 Hldgs %
24%
Holding
1,089
New
126
Increased
335
Reduced
435
Closed
161

Top Buys

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$146M
2
ADP icon
Automatic Data Processing
ADP
+$135M
3
MRK icon
Merck
MRK
+$120M
4
ODFL icon
Old Dominion Freight Line
ODFL
+$110M
5
NVDA icon
NVIDIA
NVDA
+$106M

Sector Composition

Rank Sector Weight
1 Technology 31.35%
2 Financials 14.63%
3 Consumer Discretionary 13.11%
4 Healthcare 11.31%
5 Industrials 9.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KZR
926
DELISTED
Kezar Life Sciences
KZR
$48K ﹤0.01%
5,322
-91,762
-95% -$836K
SHCR
927
DELISTED
Sharecare, Inc. Class A Common Stock
SHCR
$39.7K ﹤0.01%
51,712
-276,761
-84% -$277K
FOSL icon
928
Fossil Group
FOSL
$251M
$15.2K ﹤0.01%
14,864
-843,900
-98% -$942K
ABSI icon
929
Absci
ABSI
$1.18B
-14,042
Closed -$59K
ACAD icon
930
Acadia Pharmaceuticals
ACAD
$4.44B
-105,396
Closed -$3.3M
ACLS icon
931
Axcelis
ACLS
$3.6B
-34,481
Closed -$4.47M
ACRS icon
932
Aclaris Therapeutics
ACRS
$721M
-748,775
Closed -$786K
ACRV icon
933
Acrivon Therapeutics
ACRV
$62.9M
-46,072
Closed -$227K
ADPT icon
934
Adaptive Biotechnologies
ADPT
$3.56B
-428,858
Closed -$2.1M
AL
935
DELISTED
Air Lease Corp
AL
-463,712
Closed -$19.4M
ALLK
936
DELISTED
Allakos
ALLK
-271,455
Closed -$741K
AMWD
937
DELISTED
American Woodmark
AMWD
-3,028
Closed -$281K
AN icon
938
AutoNation
AN
$7.65B
-7,233
Closed -$1.09M
ARLO icon
939
Arlo Technologies
ARLO
$1.56B
-421,795
Closed -$4.02M
ATRA icon
940
Atara Biotherapeutics
ATRA
$70.9M
-31,239
Closed -$400K
ATXS
941
DELISTED
Astria Therapeutics
ATXS
-152,732
Closed -$1.17M
AXTI icon
942
AXT Inc
AXTI
$2.62B
-43,359
Closed -$104K
BHE icon
943
Benchmark Electronics
BHE
$2.65B
-200,415
Closed -$5.54M
BLUE
944
DELISTED
bluebird bio
BLUE
-36,750
Closed -$1.01M
BV icon
945
BrightView Holdings
BV
$1.26B
-259,723
Closed -$2.19M
CARE icon
946
Carter Bankshares
CARE
$774M
-11,293
Closed -$169K
CASH icon
947
Pathward Financial
CASH
$1.86B
-115,020
Closed -$6.09M
CCCC icon
948
C4 Therapeutics
CCCC
$385M
-100,370
Closed -$567K
CCI icon
949
Crown Castle
CCI
$33.6B
-2,088
Closed -$241K
CCO icon
950
Clear Channel Outdoor Holdings
CCO
$1.23B
-524,789
Closed -$955K

Similar funds

Jacobs Levy Equity Management's Q1 2024 Portfolio in Review

As of Q1 2024, Jacobs Levy Equity Management held 1,089 positions worth $22.4B, up 13% from $19.8B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Jacobs Levy Equity Management's Q1 2024 filing shows 126 new, 335 increased, 435 reduced and 161 closed positions. Its largest new stake was Crown Holdings: 378,261 shares worth $30M. The largest sale was AutoZone, an estimated $171M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, down from 33% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Jacobs Levy Equity Management's largest Q1 2024 buy was Crown Holdings: 378,261 shares worth $30M.
  • Jacobs Levy Equity Management added most to Apple in Q1 2024, an estimated $146M increase.
  • Jacobs Levy Equity Management's biggest Q1 2024 reduction was AutoZone, cutting an estimated $171M.
  • Jacobs Levy Equity Management fully exited Fidelity National Information Services in Q1 2024, selling an estimated $94.5M.
  • Jacobs Levy Equity Management's ten largest holdings make up 24% of its $22.4B portfolio in Q1 2024.
  • Jacobs Levy Equity Management opened 126 new positions and closed 161 in Q1 2024.
  • Jacobs Levy Equity Management's portfolio value rose 13% quarter-over-quarter to $22.4B.

Based on Jacobs Levy Equity Management's 13F filing for Q1 2024, filed 15 May 2024.